{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:49:54Z","timestamp":1778741394117,"version":"3.51.4"},"reference-count":20,"publisher":"American Veterinary Medical Association (AVMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2013,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To evaluate the outcome following urethral stent placement for the palliative treatment of obstructive carcinoma of the urethra in dogs.<\/jats:p>\n<jats:p><jats:bold>Design<\/jats:bold>\u2014Retrospective case series.<\/jats:p>\n<jats:p><jats:bold>Animals<\/jats:bold>\u201442 dogs with obstructive carcinoma of the urethra.<\/jats:p>\n<jats:p><jats:bold>Procedures<\/jats:bold>\u2014Medical records for dogs in which a self-expanding metallic stent (SEMS) was used for the treatment of obstructive carcinoma of the urethra were reviewed. Signalment, diagnostic findings, clinical signs before and after SEMS placement, and patient outcome were analyzed. Fluoroscopic images were evaluated to determine the effects of stent size, obstruction length, tumor length, and urethral length and width on the incidence of incontinence or stranguria.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014Resolution of urinary tract obstruction was achieved in 41 of 42 (97.6%) dogs. After SEMS placement, 6 of 23 male and 5 of 19 female dogs developed severe incontinence, and 1 of 23 male and 1 of 17 female dogs developed stranguria. Stent length, diameter, and location were not associated with incidence of incontinence or stranguria. Median survival time after SEMS placement was 78 days (range, 7 to 536 days). Treatment with NSAIDs before and chemotherapeutics after SEMS placement increased median survival time to 251 days (range, 8 to 536 days).<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014Urethral SEMS placement was an effective palliative treatment for dogs with obstructive carcinoma of the urethra; however, severe incontinence subsequently developed in 11 of 42 (26%) treated dogs. Adjunctive treatment of affected dogs with NSAIDs and chemotherapeutics significantly increased the median survival time.<\/jats:p>","DOI":"10.2460\/javma.242.1.59","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T19:09:04Z","timestamp":1355339344000},"page":"59-68","source":"Crossref","is-referenced-by-count":78,"title":["Evaluation of outcome following urethral stent placement for the treatment of obstructive carcinoma of the urethra in dogs: 42 cases (2004\u20132008)"],"prefix":"10.2460","volume":"242","author":[{"given":"Amanda L.","family":"Blackburn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson C.","family":"Berent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chick W.","family":"Weisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1939-1676.2003.tb02424.x","article-title":"Canine transitional cell carcinoma. A review","volume":"17","author":"Mutsaers","year":"2003"},{"key":"ref2","series-title":"Urol Oncol","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1078-1439(99)00006-X","article-title":"Naturally-occurring canine transitional cell carcinoma of the urinary bladder: a relevant model of human invasive bladder cancer","volume":"5","author":"Knapp","year":"2000"},{"key":"ref3","series-title":"J Comp Pathol","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0021-9975(05)80027-1","article-title":"Pathology of canine bladder and urethral cancer and correlation with tumor progression and survival","volume":"113","author":"Valli","year":"1995"},{"key":"ref4","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1939-1676.1992.tb00330.x","article-title":"Canine bladder and urethral tumors: a retrospective study of 115 cases (1980\u20131985)","volume":"6","author":"Norris","year":"1992"},{"key":"ref5","series-title":"Clin Cancer Res","first-page":"906","article-title":"Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma","volume":"9","author":"Henry","year":"2003"},{"key":"ref6","series-title":"J Am Anim Hosp Assoc","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5326\/0400131","article-title":"Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study","volume":"40","author":"Poirier","year":"2004"},{"key":"ref7","series-title":"J Am Anim Hosp Assoc","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5326\/15473317-32-1-29","article-title":"Management and complications following trigonal-colonic anastomosis in a dog: five-year evaluation","volume":"32","author":"Smith","year":"1996"},{"key":"ref8","series-title":"Vet Surg","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1532-950X.1991.tb00316.x","article-title":"Enterocystoplasty with cystectomy and subtotal intracapsular prostatectomy in male dogs","volume":"20","author":"Fries","year":"1991"},{"key":"ref9","series-title":"Vet Surg","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1532-950X.1988.tb00293.x","article-title":"Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma","volume":"17","author":"Stone","year":"1988"},{"key":"ref10","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2460\/javma.229.2.226","article-title":"Evaluation of palliative stenting for management of malignant urethral obstructions in dogs","volume":"229","author":"Weisse","year":"2006"},{"key":"ref11","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2460\/javma.2003.223.325","article-title":"Clinical use of low-prolife cystostomy tubes in four dogs and a cat","volume":"223","author":"Stiffler","year":"2003"},{"key":"ref12","series-title":"Vet Surg","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1532-950x.2004.04067.x","article-title":"Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs","volume":"33","author":"Liptak","year":"2004"},{"key":"ref13","series-title":"Curr Urol Rep","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11934-007-0008-6","article-title":"Managing the local complications of locally advanced prostate cancer","volume":"8","author":"Anast","year":"2007"},{"key":"ref14","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2460\/javma.228.4.549","article-title":"Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma","volume":"228","author":"Upton","year":"2006"},{"key":"ref15","series-title":"Incontinence"},{"key":"ref16","series-title":"Withrow and MacEwen's small animal clinical oncology","first-page":"642","article-title":"Prostatic neoplasia","author":"Fan","year":"2007"},{"key":"ref17","series-title":"Vet Radiol Ultrasound","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1740-8261.2002.tb00443.x","article-title":"Needle tract implantation following ultrasound-guided fine needle aspiration biopsy of transitional cell carcinoma of the bladder, urethra, and prostate","volume":"43","author":"Nyland","year":"2002"},{"key":"ref18","series-title":"Kirk's current veterinary therapy small animal practice","first-page":"896","article-title":"Urethral sphincter mechanism incompetence in male dogs","author":"Arnold","year":"2000"},{"key":"ref19","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1939-1676.1994.tb03232.x","article-title":"Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder","volume":"8","author":"Knapp","year":"1994"},{"key":"ref20","series-title":"Mol Cancer Ther","first-page":"183","article-title":"Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer","volume":"2","author":"Mohammed","year":"2003"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/242\/1\/javma.242.1.59.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/242\/1\/javma.242.1.59.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/242\/1\/javma.242.1.59.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:36:39Z","timestamp":1741347399000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/242\/1\/javma.242.1.59.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":20,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2460\/javma.242.1.59","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,1]]}}}